Pharma Consult ApS — Credit Rating and Financial Key Figures
CVR number: 43801708
Jespervej 58, 3400 Hillerød
Income statement (kDKK)
2023 | 2024 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 1 454.12 | 1 390.55 |
| Employee benefit expenses | - 790.07 | - 782.51 |
| EBIT | 664.05 | 608.04 |
| Other financial expenses | -5.47 | -12.71 |
| Pre-tax profit | 658.58 | 595.33 |
| Income taxes | - 148.63 | - 133.03 |
| Net earnings | 509.94 | 462.29 |
Assets (kDKK)
2023 | 2024 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Current trade debtors | 318.17 | 150.74 |
| Current other receivables | 4.33 | 1.10 |
| Short term receivables total | 322.50 | 151.84 |
| Cash and bank deposits | 562.25 | 1 263.60 |
| Cash and cash equivalents | 562.25 | 1 263.60 |
| Balance sheet total (assets) | 884.75 | 1 415.44 |
Equity and liabilities (kDKK)
2023 | 2024 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Retained earnings | -0.00 | 509.94 |
| Profit of the financial year | 509.94 | 462.29 |
| Shareholders equity total | 549.94 | 1 012.23 |
| Non-current liabilities total | ||
| Current loans from credit institutions | 0.01 | 0.01 |
| Current trade creditors | 12.01 | 5.94 |
| Current owed to participating | 4.77 | 100.61 |
| Short-term deferred tax liabilities | 148.63 | 133.03 |
| Other non-interest bearing current liabilities | 169.38 | 163.61 |
| Current liabilities total | 334.81 | 403.20 |
| Balance sheet total (liabilities) | 884.75 | 1 415.44 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.